Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


One Week To Go: Final GGB Awards Entry Deadline Looms

Final Deadline For Global Generics & Biosimilars Awards Entries Is 4 September

Executive Summary

There is now just over a week to go until the final deadline for entries to the Global Generics & Biosimilars Awards 2023.

Entrants hoping to compete in the Global Generics & Biosimilars Awards 2023 now have just one more week to finalize their submissions, ahead of our final entry deadline of 4 September.

The awards – which remain free to enter and attend – will close for entries after 4 September, with no deadline extensions for firms and individuals to submit their achievements for consideration after this date.

After submissions close on 4 September, all received entries will be sent out for consideration by our panel of expert judges, with a final shortlist to be compiled ahead of the awards ceremony that will take place on Wednesday 25 October at the Hotel Porta Fira in Barcelona. (Also see "GGB Awards Returns To Barcelona In Its 10th Year" - Generics Bulletin, 23 Feb, 2023.)

Nominations can cover any activities that took place between 1 August 2022 and 31 August 2023.

This year, the Awards are once again backed by our headline sponsor, IQVIA – along with category sponsors Adalvo, Pharmacloud and Pharmawise – and supported by International Health Partners, the International Generic and Biosimilar Medicines Association, and the US Association for Accessible Medicines and its Biosimilars Council.

Generics Bulletin’s editors recently discussed details of the event in a podcast, including a breakdown of our 14 categories and tips on how to make your entries stand out and convince our judges why you deserve to win (see sidebar).

Across our categories, the Global Generics & Biosimilars Awards covers an array of industry activities.

This year, we have introduced a new category recognizing promotional campaigns in addition to our 13 other regular categories.

Alongside the global and regional Company of the Year awards – recognizing the world leader as well as top companies in the EMEA, Americas and Asia-Pacific regions – our categories also include Business Development of the Year, Acquisition of the Year and Industry Partner of the Year, while other specific categories also cover Biosimilars and Value Added Medicines.

Outstanding achievements in company leadership and corporate social responsibility are also honored during the ceremony.

For full details of the awards, including our categories, sponsors and how to enter and attend, click here.

To enquire about sponsorship opportunities for the Global Generics & Biosimilars Awards 2023, please e-mail [email protected]

And to register interest in attending the Global Generics & Biosimilars Awards 2023, to receive the latest updates and for any further details, please e-mail [email protected]

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts